{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:51:10Z","timestamp":1791831070439,"version":"4.3.4"},"reference-count":116,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,3,26]],"date-time":"2009-03-26T00:00:00Z","timestamp":1238025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Alcoholic hepatitis is a severe, cholestatic liver disease occurring in patients with alcohol abuse. Mortality is substantial; however, therapies may improve clinical outcomes.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To provide an updated review of the epidemiology, diagnosis, staging and treatment of alcoholic hepatitis.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> A MEDLINE literature search was performed to identify pertinent articles. Relevant clinical abstracts were also reviewed.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Severe alcoholic hepatitis occurs in a small fraction of patients who abuse alcohol. The 28\u2010day mortality ranges from 30% to 50% in most series. Diagnosis is generally based on clinical features, with a limited role for liver biopsy. Beneficial treatment options include alcohol abstinence and nutritional therapy. Despite variable results in clinical trials, corticosteroids and pentoxifylline appear to provide moderate survival benefit. Anti\u2010tumour necrosis factor agents and antioxidants have not proven beneficial, and should be limited to clinical trials. Liver transplant is not a frequent option given the active or recent alcohol use.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Severe alcoholic hepatitis is a clinically\u2010diagnosed condition associated with significant mortality. Alcohol abstinence and nutritional therapy have been associated with improved clinical parameters and should be considered in all patients. Corticosteroid therapy and pentoxifylline therapy appear to show moderate survival benefit and should be considered as first\u2010line therapeutic agents.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2009.04002.x","type":"journal-article","created":{"date-parts":[[2009,3,26]],"date-time":"2009-03-26T09:53:12Z","timestamp":1238061192000},"page":"3-13","source":"Crossref","is-referenced-by-count":31,"title":["Review article: the diagnosis and management of alcoholic hepatitis"],"prefix":"10.1111","volume":"30","author":[{"given":"S. M.","family":"COHEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"AHN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,6,15]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(78)90401-8"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-110-9-685"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840170407"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.11.039"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.03.027"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.6.845"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-832936"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-960170"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000095862.30777.D9"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250120"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230513"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)92831-9"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200205000-00019"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01324898"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01006.x"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1521-6918(03)00018-0"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02989216"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9099-z"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90154-5"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(79)91064-7"},{"key":"e_1_2_9_22_2","first-page":"231A","article-title":"Interet de la biopsie hepatique pour la selection des sujets suspects d\u2019hepatitis alcoolique aigue. Journees francophones d\u2019hepatologie et de pathologies digestives","volume":"16","author":"Mathurin P","year":"1992","journal-title":"Gastroenterol Clin Biol"},{"key":"e_1_2_9_23_2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0016-5085(82)80325-9","article-title":"Transvenous liver biopsy: an experience based on 1000 hepatic tisuue samplings with the procedure","volume":"83","author":"Lebrec D","year":"1982","journal-title":"Gastroenterology"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.24.11.1057"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22742"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90034-A"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2004.11.001"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007346"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00190-8"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21298"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03369.x"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22172"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21563"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20503"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.12.022"},{"key":"e_1_2_9_36_2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-0038-1661258","article-title":"International Committee for Standardization in Haematology, International Committee on Thrombosis and Haemostasis: ICSH\/ICTH recommendations for reporting prothrombin time in oral anticoagulant control","volume":"53","year":"1985","journal-title":"Thromb Haemost"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01881.x"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7933.2008.02827.x"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.050781"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.099226"},{"key":"e_1_2_9_41_2","first-page":"515","article-title":"Natural history of alcoholic hepatitis. II. The long\u2010term prognosis","volume":"56","author":"Alexander JF","year":"1971","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(68)90111-3"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.17.2003"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2006.02.002"},{"key":"e_1_2_9_45_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881103174017"},{"key":"e_1_2_9_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/0-306-47939-7_16"},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/37.5.504"},{"key":"e_1_2_9_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000141640.48924.14"},{"key":"e_1_2_9_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61814-5"},{"key":"e_1_2_9_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)91098-Q"},{"key":"e_1_2_9_51_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196010132631505"},{"key":"e_1_2_9_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(84)90776-9"},{"key":"e_1_2_9_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/43.2.213"},{"key":"e_1_2_9_54_2","doi-asserted-by":"publisher","DOI":"10.1177\/0115426506021003245"},{"key":"e_1_2_9_55_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-832941"},{"key":"e_1_2_9_56_2","doi-asserted-by":"publisher","DOI":"10.1079\/BJN19930068"},{"key":"e_1_2_9_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840080622"},{"key":"e_1_2_9_58_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528009181484"},{"key":"e_1_2_9_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2005.07.002"},{"key":"e_1_2_9_60_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpgasthep0443"},{"key":"e_1_2_9_61_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01660.x"},{"key":"e_1_2_9_62_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.8627"},{"key":"e_1_2_9_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2006.01.018"},{"key":"e_1_2_9_64_2","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.1995.10718487"},{"key":"e_1_2_9_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0b013e3282f9e870"},{"key":"e_1_2_9_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00587.x"},{"key":"e_1_2_9_67_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.1.113"},{"key":"e_1_2_9_68_2","first-page":"223","article-title":"[Corticoid therapy in the treatment of acute alcoholic hepatitis. Results of a meta\u2010analysis]","volume":"15","author":"Daures JP","year":"1991","journal-title":"Gastroenterol Clin Biol"},{"key":"e_1_2_9_69_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-4-299"},{"key":"e_1_2_9_70_2","first-page":"208","article-title":"Treatment of alcoholic hepatitis","volume":"2","author":"Reynolds TB","year":"1989","journal-title":"Gastroenterol Int"},{"key":"e_1_2_9_71_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-74-3-311"},{"key":"e_1_2_9_72_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197106172842404"},{"key":"e_1_2_9_73_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-79-5-625"},{"key":"e_1_2_9_74_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01072499"},{"key":"e_1_2_9_75_2","first-page":"1100","article-title":"Risk factors and therapy in alcoholic hepatitis (AH)","volume":"72","author":"Mendenhall CL","year":"1977","journal-title":"Gastroenterology"},{"key":"e_1_2_9_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(78)90790-4"},{"key":"e_1_2_9_77_2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0016-5085(78)90814-4","article-title":"Unpublished trial. Quoted by Conn HO. Steroid treatment of alcoholic hepatitis. The yeas and the nays","volume":"74","author":"Galambos JT","year":"1978","journal-title":"Gastroenterology"},{"key":"e_1_2_9_78_2","first-page":"443","article-title":"A controlled trial of 6\u2010methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patients","volume":"69","author":"Shumaker JB","year":"1978","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_9_79_2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0016-5085(80)90867-7","article-title":"Double\u2010blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy","volume":"78","author":"Depew W","year":"1980","journal-title":"Gastroenterology"},{"key":"e_1_2_9_80_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.23.1.75"},{"key":"e_1_2_9_81_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198412063112302"},{"key":"e_1_2_9_82_2","first-page":"769","article-title":"Prednisolone treatment of alcoholic hepatitis: forty\u2010five cases","volume":"16","author":"Bories P","year":"1987","journal-title":"Presse Med"},{"key":"e_1_2_9_83_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202203260802"},{"key":"e_1_2_9_84_2","first-page":"S75","article-title":"Influence of corticosteroids (CS) on plasma cytokines concentrations in patients with severe alcoholic hepatitis (AH): results of a randomized study","volume":"18","author":"Richardet JP","year":"1993","journal-title":"J Hepatol"},{"key":"e_1_2_9_85_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03685.x"},{"key":"e_1_2_9_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00289-6"},{"issue":"1","key":"e_1_2_9_87_2","first-page":"635A","article-title":"Corticosteroids improve 28\u2010day survival in patients with severe alcoholic hepatitis: individual data analysis of the last 5 randomized controlled trials","volume":"48","author":"Mathurin P","year":"2008","journal-title":"Hepatology"},{"key":"e_1_2_9_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hep.2003.09.038"},{"key":"e_1_2_9_89_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21607"},{"key":"e_1_2_9_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.10.010"},{"key":"e_1_2_9_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(88)81271-3"},{"key":"e_1_2_9_92_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.20189"},{"issue":"1","key":"e_1_2_9_93_2","first-page":"373A","article-title":"Pentoxfylline reduces disease severity and prevents renal impairment in severe acute alcoholic hepatitis: a double blind, placebo controlled trial","volume":"44","author":"Sidhu S","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"e_1_2_9_94_2","first-page":"492A","article-title":"The influence of Pentoxfylline on mortality in alcoholic hepatitis and benefit of the Glascow Alcoholic Hepatitis Score (GAHS)","volume":"42","author":"Macavoy NC","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"e_1_2_9_95_2","first-page":"493A","article-title":"Evaluation of Pentoxfylline in patients with severe alcoholic hepatitis non responders to corticosteroids: a pilot controlled study","volume":"42","author":"Louvet A","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"e_1_2_9_96_2","first-page":"249A","article-title":"Pentoxifylline for the treatment of patients with advanced cirrhosis. A randomized, placebo\u2010controlled, double\u2010blind trial","volume":"46","author":"Lebrec D","year":"2007","journal-title":"Hepatology"},{"key":"e_1_2_9_97_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00171.2004"},{"key":"e_1_2_9_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00230-1"},{"key":"e_1_2_9_99_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.8.1182"},{"key":"e_1_2_9_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00442-7"},{"key":"e_1_2_9_101_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20206"},{"key":"e_1_2_9_102_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.08.057"},{"key":"e_1_2_9_103_2","first-page":"CD003328","article-title":"Interventions for paracetamol (acetaminophen) overdose","volume":"2","author":"Brok J","year":"2006","journal-title":"Cochrane Database Syst Rev (Online)"},{"key":"e_1_2_9_104_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563659809028022"},{"key":"e_1_2_9_105_2","first-page":"474","volume-title":"Biological Approach to Alcoholism","author":"Israel Y","year":"1983"},{"key":"e_1_2_9_106_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.72.3.1137"},{"key":"e_1_2_9_107_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198712033172301"},{"key":"e_1_2_9_108_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0676.2001.210606.x"},{"key":"e_1_2_9_109_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002800.pub2"},{"key":"e_1_2_9_110_2","first-page":"CD003045","article-title":"Anabolic\u2010androgenic steroids for alcoholic liver disease","volume":"4","author":"Rambaldi A","year":"2006","journal-title":"Cochrane Database Syst Rev (Online)"},{"key":"e_1_2_9_111_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.00262.x"},{"key":"e_1_2_9_112_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20704"},{"key":"e_1_2_9_113_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20934"},{"key":"e_1_2_9_114_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520410009591"},{"key":"e_1_2_9_115_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20688"},{"key":"e_1_2_9_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00088-6"},{"key":"e_1_2_9_117_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.500030305"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2009.04002.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2009.04002.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T19:51:43Z","timestamp":1697226703000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2009.04002.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,15]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1111\/j.1365-2036.2009.04002.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04002.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,15]]}}}